Pain
Conditions
Interventions
Group A:Ultrasound-guided interscalene block with injection of 20 ml of 0.33% ropivacaine
Group B:Ultrasound-guided combined suprascapular and axillary nerve block with injection of 10 ml of 0.33% ropivacaine to each nerve
GroupC:Ultrasound-guided infraspinatus-teres minor interfascial block with injection of 20 ml of 0.33% ropivacaine
Sponsors
Tianjin Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Patients undergoing unilateral shoulder arthroscopy. 2.Age between 18 and 65 years (inclusive). 3.American Society of Anesthesiologists (ASA) physical status classification I to III. 4.The patient or the patient's legal representative is capable and willing to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients with severe cardiac, hepatic, or renal disease, or coagulopathy. 2.Patients with pre-existing neurological deficits or pathologies affecting nerve block, or those who refuse regional anesthesia. 3.Patients with known allergy to local anesthetics, or infection, skin breakdown, or ulceration at the proposed puncture site(s). 4.Patients with psychiatric disorders precluding cooperation with the study procedures or follow-up. 5.Patients with opioid dependence. 6.Patients who decline patient-controlled analgesia (PCA). 7.Pregnant or lactating women. 8.Patients who refuse to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative VAS Scores;Rebound Tenderness Incidence;Diaphragm Thickness Change Rate and Diaphragm Excursion Pre- versus Postoperatively;Postoperative Quality of Recovery-15 (QoR-15) Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative Anesthetic Consumption;Adverse Reaction Incidence; | — |
Countries
China
Contacts
Public ContactLina Zhao
Department of Anesthesiology, Tianjin Hospital
Outcome results
None listed